High blood pressure is one of the most common health problems in the world. Millions of people take medicine every day to keep their blood pressure under control.
If blood pressure stays too high for too long, it can damage blood vessels and increase the risk of serious problems such as heart attacks, strokes, and heart failure. Because of these risks, doctors usually start treatment as soon as high blood pressure is diagnosed.
There are several different types of medicines used to treat high blood pressure. Doctors often choose between five main groups.
These include thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers (often called ARBs), dihydropyridine calcium channel blockers, and non‑dihydropyridine calcium channel blockers. Each type works in a different way to lower blood pressure.
For many years, doctors have often chosen ACE inhibitors as the first medicine for patients who need treatment. ACE inhibitors help relax blood vessels so blood can flow more easily. This lowers pressure in the arteries and reduces strain on the heart. Because these drugs have been widely used for decades, many doctors feel comfortable prescribing them.
However, a new study from researchers at Columbia University suggests that another type of medicine may actually be a better first choice for many people.
The study looked closely at thiazide diuretics, a group of drugs that help the body remove extra salt and water through urine. By reducing fluid in the bloodstream, these medicines lower blood pressure and reduce the workload on the heart.
The research team wanted to understand which medicines truly work best when people start blood pressure treatment for the first time. Instead of relying only on expert opinions or smaller clinical trials, the researchers used a very large amount of real-world health data.
They examined medical records and insurance claims from nearly five million patients who had just begun treatment for high blood pressure. This large dataset allowed scientists to compare how different medicines performed in everyday medical practice across many different groups of people.
The researchers discovered that almost half of the patients in the study were first given ACE inhibitors. About 48 percent started treatment with this type of drug. In contrast, only about 17 percent of patients were started on thiazide diuretics.
When the researchers compared the outcomes of these two groups, they found something surprising. Patients who began treatment with thiazide diuretics had better overall health results than those who started with ACE inhibitors.
In fact, people who used thiazide diuretics as their first treatment were about 15 percent less likely to experience serious heart‑related problems. These problems included heart attacks, strokes, and heart failure. Since these are among the most dangerous complications of high blood pressure, the difference is considered very important.
The study also looked at side effects. All medicines can cause unwanted reactions in some people, and understanding these risks helps doctors choose the safest option. The researchers found that patients taking ACE inhibitors experienced more side effects overall.
In total, ACE inhibitor users showed 19 different types of side effects more often than people taking thiazide diuretics. One of the best known side effects of ACE inhibitors is a dry cough that can last for a long time and become very uncomfortable. Another possible problem is high potassium levels in the blood, which can be dangerous in some situations.
People who started treatment with thiazide diuretics had fewer of these issues. This suggests that thiazide medicines may be easier for many patients to tolerate.
The lead researcher, Dr. George Hripcsak from Columbia University, and his colleagues also tried to estimate how many health problems could have been prevented if patients had been given thiazide diuretics instead of ACE inhibitors.
Their analysis suggested that around 3,100 major heart problems might have been avoided if those patients had started with thiazides. This finding highlights how important the first treatment choice can be when managing high blood pressure.
The researchers believe that these results should encourage doctors to rethink which medicines they prescribe first. While ACE inhibitors are still useful drugs and may be the best choice for some patients, thiazide diuretics may offer better protection against heart disease for many people.
The study also shows the value of using large health databases to study treatments. By analyzing information from millions of patients, scientists can see patterns that may not appear in smaller studies. This approach helps provide clearer guidance for doctors and improves patient care.
The findings of this research were published in the medical journal The Lancet. Because the study involved such a large number of patients and carefully compared different treatments, many experts believe it provides strong evidence for reconsidering current treatment habits.
For people living with high blood pressure, this research is encouraging. It suggests that doctors may be able to choose treatments that not only lower blood pressure but also reduce the chances of serious heart problems in the future.
As always, patients should talk with their doctors before making any changes to their medications. The best treatment plan depends on many factors, including a person’s age, overall health, and other medical conditions.
Still, this study offers an important reminder that even widely used medicines should continue to be carefully studied. New evidence can help doctors make better decisions and help patients live longer and healthier lives.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
The research findings were published in The Lancet.
Copyright © 2026 Knowridge Science Report. All rights reserved.
